NEW APPROACHES TO THERAPY FOR MASTOCYTOSIS: A Case for Treatment With kitKinase Inhibitors
Authors:
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 14 (3) , 689-695
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of Spontaneous Receptor Phosphorylation by Residues in a Putative α-Helix in the KIT Intracellular Juxtamembrane RegionJournal of Biological Chemistry, 1999
- Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosisProceedings of the National Academy of Sciences, 1999
- Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell NeoplasmsJournal of Investigative Dermatology, 1999
- Identification of Activating c-kit Mutations in Adult-, but not in Childhood-Onset Indolent Mastocytosis: A Possible Explanation for Divergent Clinical BehaviorJournal of Investigative Dermatology, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Establishment of Two Dog Mastocytoma Cell Lines in Continuous CultureAmerican Journal of Respiratory Cell and Molecular Biology, 1990
- Isolated canine mastocytoma cells: propagation and characterization of two cell linesAmerican Journal of Physiology-Cell Physiology, 1986